Naohisa Ogo Selected Research

Naohisa Ogo Research Topics

Disease

16	Neoplasms (Cancer) 02/2022 - 03/2010
2	Glioblastoma (Glioblastoma Multiforme) 03/2016 - 07/2013
2	Lymphoma (Lymphomas) 05/2011 - 11/2010
1	Lung Neoplasms (Lung Cancer) 02/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022
1	Residual Neoplasm 02/2022
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 01/2022
1	Heart Failure 02/2021
1	Fibrosis (Cirrhosis) 10/2020
1	Mouth Neoplasms (Oral Cancer) 05/2020
1	Caliciviridae Infections 04/2017
1	Glioma (Gliomas) 03/2016
1	Brain Neoplasms (Brain Tumor) 03/2016
1	Drug-Related Side Effects and Adverse Reactions 03/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2010
1	Hematologic Neoplasms (Hematological Malignancy) 12/2010

Drug/Important Bio-Agent (IBA)

5	STX-0119IBA 10/2020 - 11/2010
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022 - 01/2019
4	SurvivinIBA 05/2020 - 03/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 11/2010
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
2	YHO-1701IBA 02/2022 - 05/2020
2	TOR Serine-Threonine KinasesIBA 01/2022 - 03/2016
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 03/2010
2	3-tritylthio-L-alanineIBA 04/2021 - 12/2010
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 01/2019
1	Anaplastic Lymphoma KinaseIBA 02/2022
1	alectinibIBA 02/2022
1	Tyrosine Kinase InhibitorsIBA 02/2022
1	RNA (Ribonucleic Acid)IBA 02/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Dynamin IIIBA 01/2022
1	AntigensIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	LipidsIBA 01/2022
1	ProdrugsIBA 04/2021
1	KinesinsIBA 04/2021
1	Amino Acids FDA Link 04/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	NSC 74859IBA 10/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	Antiviral Agents (Antivirals)IBA 04/2017
1	Indicators and Reagents (Reagents)IBA 04/2017
1	Disinfectants (Biocides)IBA 04/2017
1	Bendamustine Hydrochloride FDA Link 01/2017
1	Alkylating AgentsIBA 01/2017
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2016
1	Fluvoxamine (Luvox)FDA LinkGeneric 03/2016
1	Epirubicin (Ellence)FDA LinkGeneric 01/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2016
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2014
1	GTP Phosphohydrolases (GTPases)IBA 01/2014
1	Dynamins (Dynamin)IBA 01/2014
1	BenzenesulfonamidesIBA 03/2012
1	Tryptophan (L-Tryptophan)FDA Link 03/2012
1	KynurenineIBA 03/2012
1	Cyclin D1IBA 05/2011
1	CaspasesIBA 12/2010
1	Oncogene Proteins (Oncogene Protein)IBA 11/2010

Therapy/Procedure

5	Therapeutics 01/2022 - 03/2012
1	Aftercare (After-Treatment) 02/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Immunotherapy 01/2022
1	Oral Administration 11/2010